Palisade Asset Management LLC increased its holdings in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 9.1% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 231,553 shares of the pharmacy operator’s stock after purchasing an additional 19,326 shares during the period. Walgreens Boots Alliance makes up approximately 2.2% of Palisade Asset Management LLC’s holdings, making the stock its 12th largest position. Palisade Asset Management LLC’s holdings in Walgreens Boots Alliance were worth $16,880,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also bought and sold shares of the company. WoodTrust Financial Corp lifted its stake in shares of Walgreens Boots Alliance by 2.1% in the 3rd quarter. WoodTrust Financial Corp now owns 31,178 shares of the pharmacy operator’s stock valued at $2,273,000 after purchasing an additional 656 shares during the period. Parkside Financial Bank & Trust lifted its stake in shares of Walgreens Boots Alliance by 10.1% in the 3rd quarter. Parkside Financial Bank & Trust now owns 7,649 shares of the pharmacy operator’s stock valued at $557,000 after purchasing an additional 703 shares during the period. Hugh Johnson Advisors LLC lifted its stake in shares of Walgreens Boots Alliance by 11.0% in the 2nd quarter. Hugh Johnson Advisors LLC now owns 7,801 shares of the pharmacy operator’s stock valued at $468,000 after purchasing an additional 773 shares during the period. World Asset Management Inc lifted its stake in shares of Walgreens Boots Alliance by 1.4% in the 2nd quarter. World Asset Management Inc now owns 58,572 shares of the pharmacy operator’s stock valued at $3,515,000 after purchasing an additional 807 shares during the period. Finally, Busey Trust CO lifted its stake in shares of Walgreens Boots Alliance by 8.1% in the 3rd quarter. Busey Trust CO now owns 10,824 shares of the pharmacy operator’s stock valued at $789,000 after purchasing an additional 812 shares during the period. 61.96% of the stock is owned by institutional investors and hedge funds.

A number of research analysts have recently weighed in on the company. Pivotal Research increased their price target on Walgreens Boots Alliance from $60.00 to $72.00 and gave the company a “hold” rating in a research note on Monday. Zacks Investment Research raised Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $79.00 price target on the stock in a research note on Saturday, October 13th. Barclays increased their price target on Walgreens Boots Alliance from $77.00 to $80.00 and gave the company an “equal weight” rating in a research note on Friday, October 12th. Robert W. Baird increased their price target on Walgreens Boots Alliance from $69.00 to $71.00 and gave the company a “neutral” rating in a research note on Friday, October 12th. Finally, Citigroup increased their price target on Walgreens Boots Alliance from $69.00 to $76.00 and gave the company a “neutral” rating in a research note on Friday, October 12th. One research analyst has rated the stock with a sell rating, eleven have issued a hold rating, seven have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average target price of $78.22.

Walgreens Boots Alliance stock traded up $0.76 during mid-day trading on Friday, hitting $77.34. 471,801 shares of the company’s stock were exchanged, compared to its average volume of 6,372,291. The company has a market capitalization of $73.07 billion, a PE ratio of 12.92, a PEG ratio of 1.16 and a beta of 1.04. Walgreens Boots Alliance Inc has a fifty-two week low of $59.07 and a fifty-two week high of $80.68. The company has a current ratio of 0.82, a quick ratio of 0.38 and a debt-to-equity ratio of 0.47.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Thursday, October 11th. The pharmacy operator reported $1.48 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.45 by $0.03. The business had revenue of $33.44 billion for the quarter, compared to the consensus estimate of $33.64 billion. Walgreens Boots Alliance had a return on equity of 21.75% and a net margin of 3.82%. Analysts predict that Walgreens Boots Alliance Inc will post 6.53 EPS for the current fiscal year.

In related news, Director William C. Foote sold 2,736 shares of the firm’s stock in a transaction on Thursday, August 2nd. The stock was sold at an average price of $65.99, for a total transaction of $180,548.64. Following the sale, the director now owns 10,943 shares of the company’s stock, valued at approximately $722,128.57. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 14.80% of the company’s stock.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.

Read More: Is the Dow Jones Industrial Average (DJIA) still relevant?

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.